BioCentury
ARTICLE | Company News

Repros endocrine/metabolic news

January 18, 2016 8:00 AM UTC

The U.S. Court of Appeals for the Federal Circuit (CAFC) upheld a district court decision that Dr. Harry Fisch, a urologist and national media personality, failed to present sufficient evidence to be added as a co-inventor of U.S. Patent Nos. 7,737,185 and 7,759,360, which cover enclomiphene. Dr. Fisch sent Repros a letter in July 2013 threatening to file a lawsuit seeking addition to the patents as well as U.S. Patent No. 7,173,064, also covering enclomiphene. In August 2013, Repros filed a suit in the U.S. District Court for the Southern District of Texas against Dr. Fisch. Dr. Fisch subsequently stipulated that he does not claim to be a co-inventor of the ‘064 patent. In December 2014, the court granted summary judgment in favor of the company and in February 2015, Dr. Fisch filed a notice of appeal in the U.S. CAFC (see BioCentury, Aug. 19, 2013). ...